Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Therapeutic Advances in Medical Oncology|February 9, 2024
Plasma ddPCR for the detection of <i>MET</i> amplification in advanced NSCLC patients: a comparative real-world studyJun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, et al.
Clinical and Translational Medicine|June 9, 2020
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR-TKIs in EGFR-mutant advanced NSCLC than BIM deletion polymorphismSi-Yang Liu, Jia-Ying Zhou, Wen-Feng Li, et al.
Cancer Treatment and Research Communications|April 30, 2023
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementQing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, et al.
Cancer Treatment and Research Communications|January 30, 2023
The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patientsYu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, et al.
The International Journal of Biological Markers|December 23, 2015
Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancerJie-Fei Han, She-Juan An, Wen-Mei Su, et al.
BMC Medicine|June 1, 2022
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastasesMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
Cancer Biology & Therapy|April 17, 2019
The <i>in cis</i> compound <i>EGFR</i> mutations in Chinese advanced non-small cell lung cancer patientsMin Li, Cheng-Zhi Zhou, Jin-Ji Yang, et al.
The Oncologist|September 17, 2014
Lung cancer treatment disparities in China: a question in need of an answerLu-Lu Yang, Xu-Chao Zhang, Xue-Ning Yang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLCYi-Long Wu, Nagahiro Saijo, Sumitra Thongprasert, et al.
Plos One|July 7, 2012
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking statusShe-Juan An, Zhi-Hong Chen, Jian Su, et al.
Pageof 18